Melissa Kapulu/Wellcome Open Res
Safety and immunogenicity of varied doses of R21/Matrix-M vaccine at three years follow-up: A phase 1b age de-escalation, dose-escalation trial in adults, children, and infants in Kilifi-Kenya.Sang S
Datoo MS
Otieno E
Muiruri C
Bellamy D
Gathuri E
Ngoto O
Musembi J
Provstgaard-Morys S
Stockdale L
Aboagye J
Woods D
Lawrie A
Roberts R
Keter K
Kimani D
Ndungu F
Kapulu M
Njau I
Orindi B
Ewer KJ
Hill AVS
Bejon P
Hamaluba M
Wellcome Open Res, (2023). 8:450
Equity for excellence in academic institutions: a manifesto for change.Wedekind L
Noe A
Mokaya J
Tamandjou C
Kapulu M
Ruecker A
Kestelyn E
Zimba M
Khatamzas E
Eziefula AC
Mackintosh CL
Nascimento R
Ariana P
Best D
Gibbs E
Dunachie S
Hadley G
Ravenswood H
Young B
Kamau C
Marsh K
McShane H
Hale R
McPhilbin E
Ovseiko PV
Oxford Equity in Academia consortium
Surender R
Worland C
White LJ
Matthews PC
Wellcome Open Res, (2021). 6:142
Engagement of ethics and regulatory authorities on human infection studies: Proceedings of an engagement workshop in Zambia.Kunda-Ng'andu EM
Simuyandi M
Kapulu M
Chirwa-Chobe M
Mwanyungwi-Chinganya H
Mwale S
Chilengi R
Sharma A
Wellcome Open Res, (2021). 6:31
